0001786949-21-000001.txt : 20210113 0001786949-21-000001.hdr.sgml : 20210113 20210113140854 ACCESSION NUMBER: 0001786949-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210113 DATE AS OF CHANGE: 20210113 EFFECTIVENESS DATE: 20210113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sparrow Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001786949 IRS NUMBER: 464189155 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-386188 FILM NUMBER: 21525809 BUSINESS ADDRESS: STREET 1: 920 SW 6TH AVE STREET 2: SUITE 1200 CITY: PORTLAND STATE: OR ZIP: 97204 BUSINESS PHONE: 312-752-8446 MAIL ADDRESS: STREET 1: 920 SW 6TH AVE STREET 2: SUITE 1200 CITY: PORTLAND STATE: OR ZIP: 97204 D 1 primary_doc.xml X0708 D LIVE 0001786949 Sparrow Pharmaceuticals, Inc. 920 SW 6TH AVE SUITE 1200 PORTLAND OR OREGON 97204 312-752-8446 DELAWARE None None Corporation true David Katz 920 SW 6th Avenue, Suite 1200 Portland OR OREGON 97204 Executive Officer Robert Jacks 920 SW 6th Avenue, Suite 1200 Portland OR OREGON 97204 Executive Officer Director Peter Thompson 920 SW 6th Avenue, Suite 1200 Portland OR OREGON 97204 Director Klaus Veitinger 920 SW 6th Avenue, Suite 1200 Portland OR OREGON 97204 Director Pharmaceuticals Decline to Disclose 06b false 2020-12-31 true true false 0 50825257 1075255 49750002 false 15 0 0 0 false Sparrow Pharmaceuticals, Inc. /s/ Robert Jacks Robert Jacks Chief Executive Officer 2021-01-13